圣诺生物
(688117)
| 流通市值：52.73亿 | | | 总市值：52.73亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 262,457,711.41 | 207,474,376.12 | 281,052,370.34 | 227,749,960.65 |
| 交易性金融资产 | 90,248,900 | 90,248,900 | 20,248,900 | 67,000,000 |
| 应收票据及应收账款 | 139,142,495.35 | 169,804,396.8 | 147,237,796.26 | 143,571,253.94 |
| 其中：应收票据 | - | 662,180 | - | - |
| 应收账款 | 139,142,495.35 | 169,142,216.8 | 147,237,796.26 | 143,571,253.94 |
| 应收款项融资 | 7,855,533.57 | 169,000 | 1,088,608.38 | 405,943 |
| 预付款项 | 33,761,841.07 | 39,816,836.16 | 14,607,319.33 | 14,635,620.92 |
| 其他应收款合计 | 6,463,055.61 | 15,711,760.53 | 14,813,363.18 | 6,667,929.2 |
| 存货 | 397,413,415.37 | 360,605,135.59 | 336,172,046.66 | 330,248,036.29 |
| 合同资产 | 38,176,135.31 | 38,158,252.27 | 29,651,731.16 | 34,921,254.72 |
| 其他流动资产 | 34,683,174.78 | 26,081,726.23 | 36,555,957.21 | 40,592,255.76 |
| 流动资产合计 | 1,010,202,262.47 | 948,070,383.7 | 881,428,092.52 | 865,792,254.48 |
| 非流动资产: | | | | |
| 长期股权投资 | 20,955,490.53 | 21,188,326.92 | 21,202,983.68 | 21,293,874.28 |
| 其他权益工具投资 | 73,405,000 | 73,405,000 | 73,405,000 | 89,405,000 |
| 其他非流动金融资产 | 66,947,648 | 66,947,648 | 62,447,648 | 40,447,648 |
| 投资性房地产 | 1,456,944.7 | 1,511,313.79 | 2,188,716.46 | 2,771,346.92 |
| 固定资产 | 639,250,359.92 | 643,096,072.22 | 658,521,306.5 | 549,329,969.85 |
| 在建工程 | 141,007,962.64 | 129,127,122.09 | 114,511,406.41 | 212,346,338.68 |
| 无形资产 | 79,803,154.86 | 80,369,959.71 | 80,936,805.9 | 80,692,946.75 |
| 开发支出 | 14,147,509.04 | 14,105,784.41 | 13,830,146.29 | 15,072,383.44 |
| 长期待摊费用 | 1,928,551.89 | 2,335,531.59 | 2,742,511.29 | 2,899,829.37 |
| 递延所得税资产 | 11,701,471.57 | 13,285,782.19 | 12,971,398.65 | 12,576,517.09 |
| 其他非流动资产 | 11,537,998.97 | 15,004,348.38 | 10,341,685.87 | 16,518,809.33 |
| 非流动资产合计 | 1,062,142,092.12 | 1,060,376,889.3 | 1,053,099,609.05 | 1,043,354,663.71 |
| 资产总计 | 2,072,344,354.59 | 2,008,447,273 | 1,934,527,701.57 | 1,909,146,918.19 |
| 流动负债: | | | | |
| 短期借款 | 234,536,653.04 | 179,516,887.06 | 205,542,601.62 | 218,153,616.25 |
| 应付票据及应付账款 | 105,081,239.79 | 81,541,132.63 | 99,569,352.13 | 101,086,484.53 |
| 其中：应付票据 | 14,811,742.42 | 10,711,722.12 | 22,486,452.12 | 26,995,248 |
| 应付账款 | 90,269,497.37 | 70,829,410.51 | 77,082,900.01 | 74,091,236.53 |
| 合同负债 | 17,213,509.87 | 15,693,020.17 | 50,884,568.04 | 19,592,142.14 |
| 应付职工薪酬 | 18,342,431.14 | 14,459,910.19 | 25,500,851.31 | 17,088,061.52 |
| 应交税费 | 17,081,690.76 | 21,675,842.96 | 17,213,413.23 | 10,403,459.17 |
| 其他应付款合计 | 53,645,182.28 | 52,434,325.25 | 48,314,701.83 | 58,485,589.67 |
| 一年内到期的非流动负债 | 67,055,464.45 | 80,773,365.83 | 179,430,259.21 | 169,701,833.34 |
| 其他流动负债 | - | 662,180 | 61,027.33 | - |
| 流动负债合计 | 512,956,171.33 | 446,756,664.09 | 626,516,774.7 | 594,511,186.62 |
| 非流动负债: | | | | |
| 长期借款 | 337,145,135.55 | 316,135,516.22 | 150,159,856.16 | 180,245,723.98 |
| 长期应付款 | 34,179,903.1 | 75,919,366.86 | 54,541,730.41 | 81,203,029.83 |
| 预计负债 | 10,979,646.64 | 10,979,646.64 | 10,979,646.64 | - |
| 递延收益 | 33,150,030.27 | 33,964,156.04 | 34,733,675.85 | 21,276,718.8 |
| 非流动负债合计 | 415,454,715.56 | 436,998,685.76 | 250,414,909.06 | 282,725,472.61 |
| 负债合计 | 928,410,886.89 | 883,755,349.85 | 876,931,683.76 | 877,236,659.23 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 220,340,369 | 157,385,978 | 157,385,978 | 157,385,978 |
| 资本公积 | 285,940,482.88 | 348,161,201.22 | 347,427,528.56 | 346,919,260.43 |
| 盈余公积 | 18,702,580.42 | 18,702,580.42 | 18,702,580.42 | 18,702,580.42 |
| 未分配利润 | 618,950,035.4 | 600,442,163.51 | 534,079,930.83 | 508,902,440.11 |
| 归属于母公司股东权益合计 | 1,143,933,467.7 | 1,124,691,923.15 | 1,057,596,017.81 | 1,031,910,258.96 |
| 股东权益合计 | 1,143,933,467.7 | 1,124,691,923.15 | 1,057,596,017.81 | 1,031,910,258.96 |
| 负债和股东权益合计 | 2,072,344,354.59 | 2,008,447,273 | 1,934,527,701.57 | 1,909,146,918.19 |
| 公告日期 | 2026-08-20 | 2026-04-24 | 2026-04-24 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |